• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福尔马林灭活疫苗对四线舌鳎免疫反应和保护效果的研究。

Immune response and protection efficacy of formalin-killed vaccines against Streptococcus iniae in four-finger threadfin Eleutheronema tetradactylum.

机构信息

Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung, Taiwan.

International Degree Program of Ornamental Fish Technology and Aquatic Animal Health, International College, National Pingtung University of Science and Technology, Neipu, Pingtung, Taiwan.

出版信息

J Fish Dis. 2024 Nov;47(11):e14009. doi: 10.1111/jfd.14009. Epub 2024 Aug 29.

DOI:10.1111/jfd.14009
PMID:39207865
Abstract

Four-finger threadfin, Eleutheronema tetradactylum farming in southern Taiwan has been facing disease problems caused by Streptococcus iniae since 2018. The development of a vaccine against infectious S. iniae in the cultured threadfin industry is necessary. Thus, this study aimed to examine the efficacy of threadfin immunized formalin-killed cells (FKC) from S. iniae GSI-111 for 42 days post-vaccination (dpv) using two doses of FKC alone (a booster at 14 dpv) as group A, and FKC mixed with ISA763A adjuvant using a single dose as group B or double doses as group C. Immunoglobulin (Ig)-M was purified from threadfin, and rabbit anti-threadfin IgM polyclonal antibodies were used to detect antibody level in immunized fish; the vaccinated group A displayed higher levels at 3 dpv and all vaccinated treatments demonstrated high antibody levels between 14 and 42 dpv. All vaccine groups showed significantly higher values of lysozyme activity at 42 dpv compared with the control group; the vaccinated A group peaked at 14 dpv. The expression profiles of pro-inflammatory and immune-related genes, TNF-α, IL-12A, and C2 were upregulated at 3 dpv, while CD8A and chemokine receptor CXCR4 were upregulated at 42 dpv. Finally, the threadfins were challenged with S. iniae at 42 dpv. The average relative percent survival was 96% for vaccination A and B treatments, and 100% for vaccination C treatment. In summary, this study demonstrated that FKC vaccines whether formulated with an adjuvant could stimulate immune response and effective protect threadfins against S. iniae infection.

摘要

台湾南部的四指马鲅(Eleutheronema tetradactylum)养殖自 2018 年以来一直面临链球菌(Streptococcus iniae)引起的疾病问题。因此,开发一种针对养殖马鲅传染性链球菌的疫苗是必要的。本研究旨在检测两种剂量的马鲅福尔马林灭活细胞(FKC)单独(在 14 天加强)作为 A 组、FKC 与 ISA763A 佐剂混合使用单次剂量作为 B 组或两次剂量作为 C 组对 42 天(dpv)后的免疫效果。从马鲅中纯化免疫球蛋白(Ig)-M,并用兔抗马鲅 IgM 多克隆抗体检测免疫鱼的抗体水平;免疫 A 组在 3 dpv 时显示出更高的水平,所有免疫组在 14 至 42 dpv 期间均显示出高抗体水平。所有疫苗组在 42 dpv 时溶菌酶活性均显著高于对照组;免疫 A 组在 14 dpv 时达到峰值。促炎和免疫相关基因 TNF-α、IL-12A 和 C2 的表达谱在 3 dpv 时上调,而 CD8A 和趋化因子受体 CXCR4 在 42 dpv 时上调。最后,在 42 dpv 时用 S. iniae 对马鲅进行攻毒。A 组和 B 组疫苗接种的平均相对存活率为 96%,C 组疫苗接种的平均相对存活率为 100%。综上所述,本研究表明,无论是否添加佐剂,FKC 疫苗都能刺激免疫反应,有效保护马鲅免受 S. iniae 感染。

相似文献

1
Immune response and protection efficacy of formalin-killed vaccines against Streptococcus iniae in four-finger threadfin Eleutheronema tetradactylum.福尔马林灭活疫苗对四线舌鳎免疫反应和保护效果的研究。
J Fish Dis. 2024 Nov;47(11):e14009. doi: 10.1111/jfd.14009. Epub 2024 Aug 29.
2
Efficacy of a formalin-inactivated vaccine against Streptococcus iniae infection in the farmed grouper Epinephelus coioides by intraperitoneal immunization.通过腹腔免疫接种,福尔马林灭活疫苗对养殖的斜带石斑鱼感染海豚链球菌的效力。
Vaccine. 2014 Dec 5;32(51):7014-7020. doi: 10.1016/j.vaccine.2014.08.039. Epub 2014 Sep 2.
3
Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.经哈维氏弧菌疫苗和无乳链球菌疫苗免疫尼罗罗非鱼的交叉免疫。
Fish Shellfish Immunol. 2020 Feb;97:382-389. doi: 10.1016/j.fsi.2019.12.021. Epub 2019 Dec 10.
4
Valuable method for production of oral vaccine by using alginate and chitosan against Lactococcus garvieae/Streptococcus iniae in rainbow trout (Oncorhynchus mykiss).利用海藻酸钠和壳聚糖生产抗鳗弧菌/无乳链球菌口服疫苗的有效方法在虹鳟鱼(Oncorhynchus mykiss)中的应用。
Fish Shellfish Immunol. 2019 Jul;90:431-439. doi: 10.1016/j.fsi.2019.05.020. Epub 2019 May 11.
5
Systemic and mucosal antibody response of freshwater cultured Asian seabass (Lates calcarifer) to monovalent and bivalent vaccines against Streptococcus agalactiae and Streptococcus iniae.淡水养殖亚洲石斑鱼(Lates calcarifer)对无乳链球菌和鳗弧菌单价和双价疫苗的系统和黏膜抗体反应。
Fish Shellfish Immunol. 2021 Jan;108:7-13. doi: 10.1016/j.fsi.2020.11.014. Epub 2020 Nov 18.
6
Differential Expression Genes of the Head Kidney and Spleen in -Infected East Asian Fourfinger Threadfin Fish ().感染斜带石斑鱼 () 后头肾和脾脏的差异表达基因。
Int J Mol Sci. 2023 Feb 14;24(4):3832. doi: 10.3390/ijms24043832.
7
The conserved surface M-protein SiMA of Streptococcus iniae is not effective as a cross-protective vaccine against differing capsular serotypes in farmed fish.海豚链球菌保守表面 M 蛋白 SiMA 作为一种交叉保护疫苗对养殖鱼类不同荚膜血清型没有效果。
Vet Microbiol. 2013 Feb 22;162(1):151-9. doi: 10.1016/j.vetmic.2012.08.018. Epub 2012 Sep 1.
8
Efficacy of a Eudragit L30D-55 encapsulated oral vaccine containing inactivated bacteria (Lactococcus garvieae/Streptococcus iniae) in rainbow trout (Oncorhynchus mykiss).含包被灭活菌(迟缓爱德华氏菌/无乳链球菌)的 Eudragit L30D-55 胶囊口服疫苗对虹鳟(Oncorhynchus mykiss)的功效。
Fish Shellfish Immunol. 2018 Oct;81:430-437. doi: 10.1016/j.fsi.2018.07.048. Epub 2018 Jul 26.
9
Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).血免疫反应和基于饲料的双价疫苗对杂交红罗非鱼(奥利亚罗非鱼×尼罗罗非鱼)链球菌和嗜水气单胞菌感染的效果。
BMC Vet Res. 2020 Jul 2;16(1):226. doi: 10.1186/s12917-020-02443-y.
10
Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus).新型盐酸金霉素抗性鮰鱼链球菌的研制及其在尼罗罗非鱼(Oreochromis niloticus)中的免疫效力。
Vaccine. 2011 Aug 11;29(35):5986-93. doi: 10.1016/j.vaccine.2011.06.036. Epub 2011 Jun 25.